iScienceBioinformaticsPeer-reviewed journal article
Using Biological Constraints to Improve Prediction in Precision Oncology
Mohamed OmariD, Wikum DinalankaraiD, Lotte Mulder, Tendai Coady, Claudio ZanettiniiD, Eddie L. ImadaiD, Laurent Younes BiD, Donald Geman, Luigi MarchionniiD
Abstract
Many gene signatures have been developed by applying machine learning (ML) on omics profiles, however, their clinical utility is often hindered by limited interpretability and unstable performance in different datasets. Here, we show the importance of embedding prior biological knowledge in the decision rules yielded by ML approaches to build robust classifiers. We tested this by applying different ML algorithms on gene expression data to predict three difficult cancer phenotypes: bladder cancer progression to muscle invasive disease; response to neoadjuvant chemotherapy in triple-negative breast cancer, and prostate cancer metastatic progression. We developed two sets of classifiers: mechanistic, by restricting the training process to features capturing a specific biological mechanism; and agnostic, in which the training didnt use any a priori biological information. Mechanistic models had a similar or better performance to their agnostic counterparts in the testing data, with enhanced stability, robustness, and interpretability. Our findings support the use of biological constraints to develop robust and interpretable gene signatures with high translational potential. MotivationOmics-based gene signatures often suffer from overfitting and reduced performance when tested on independent data. This usually results from the discrepancy between the high number of features compared to the much smaller number of samples used in the training process, which results in the machine learning algorithm perfectly fitting the training data with a subsequent deterioration in performance in independent cohorts. We introduce a mechanistic framework to mitigate overfitting and improve interpretability by constraining the training process to simple rank-based decision rules recapitulating relevant, cancer-related, biological mechanisms. Our approach aims at reducing the number of training variables to a pre-defined set of biologically important features in the form of gene pairs. The classification mechanism depends entirely on the relative ordering of these pairs, making it robust to data preprocessing techniques, improving the overall interpretability of the resulting models with significant translational implications. Most importantly, these pairs are configured in such a way that the decision rules resulting from the genes relative order embed and recapitulate specific biological mechanism, inherently enhancing the classifiers interpretability.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: machine learning (classical)
- Citations
- 10
- FWCI
- 0.89
- Field percentile
- top 32%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comprehensive evaluation of machine learning models and gene expression signatures for prostate cancer prognosis using large population cohorts
Ruidong Li, Jianguo Zhu, … Zhenyu Jia·Cancer ResearchPeer-reviewed·Mar 31, 2022
- Prediction of early breast cancer patient survival using ensembles of hypoxia signatures
Inna Y. Gong, Natalie S. Fox, … Paul Christopher Boutros·PLoS ONEPeer-reviewed·Sep 14, 2018
- Signaling Pathway Activities Improve Prognosis for Breast Cancer
Yunlong Jiao, Marta R. Hidalgo, … Joaquı́n Dopazo·bioRxiv·Apr 29, 2017
- Identifying multi-omics biomarkers for ovarian cancer survival estimation
Kosar Fateh, Srinivasulu Yerukala Sathipati·bioRxiv·Aug 10, 2026
- Interpretable per Case Weighted Ensemble Method for Cancer Associations
Adrin Jalali, Nico Pfeifer·bioRxiv·Sep 15, 2014
- MyGESig: a population-specific gene signature improves survival prediction in Malaysian breast cancer patients
Mohamad Hazwan Fikri Khairi, Zhi Lei Wong, … Pan Jia-Wern·medRxiv·Aug 28, 2025